Boris Rodenko

2.0k total citations
31 papers, 1.5k citations indexed

About

Boris Rodenko is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Boris Rodenko has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Immunology and 9 papers in Organic Chemistry. Recurrent topics in Boris Rodenko's work include Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (7 papers) and Synthesis and Biological Evaluation (7 papers). Boris Rodenko is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (7 papers) and Synthesis and Biological Evaluation (7 papers). Boris Rodenko collaborates with scholars based in Netherlands, United Kingdom and Switzerland. Boris Rodenko's co-authors include Huib Ovaa, Ton N. Schumacher, Mireille Toebes, Sine Reker Hadrup, Wim J.E. van Esch, Celia R. Berkers, Annemieke de Jong, Nella J. Nieuwkoop, Adriaan D. Bins and Miriam Coccoris and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Medicine.

In The Last Decade

Boris Rodenko

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Rodenko Netherlands 20 757 722 415 273 140 31 1.5k
Kazuhito Ohishi Japan 20 979 1.3× 419 0.6× 212 0.5× 672 2.5× 135 1.0× 30 1.7k
Alexey Stukalov Austria 17 1.5k 2.0× 312 0.4× 323 0.8× 186 0.7× 119 0.8× 36 2.1k
Viv Lindo United Kingdom 16 485 0.6× 641 0.9× 218 0.5× 186 0.7× 116 0.8× 32 1.5k
Alexander Fish Netherlands 27 1.5k 2.0× 164 0.2× 328 0.8× 147 0.5× 90 0.6× 43 1.9k
Emmanuelle Thinon United States 15 719 0.9× 169 0.2× 160 0.4× 147 0.5× 135 1.0× 21 1.1k
Venkataraman Sriram United States 20 491 0.6× 1.2k 1.6× 318 0.8× 193 0.7× 34 0.2× 38 1.7k
Toshiya Hayano Japan 25 2.2k 2.8× 576 0.8× 488 1.2× 110 0.4× 41 0.3× 45 2.5k
Shirin Arastu‐Kapur United States 17 777 1.0× 147 0.2× 390 0.9× 145 0.5× 90 0.6× 28 1.4k
Catherine Kettleborough United Kingdom 15 610 0.8× 270 0.4× 205 0.5× 125 0.5× 52 0.4× 30 1.3k
Tiina Öhman Finland 22 924 1.2× 357 0.5× 161 0.4× 267 1.0× 28 0.2× 36 1.5k

Countries citing papers authored by Boris Rodenko

Since Specialization
Citations

This map shows the geographic impact of Boris Rodenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Rodenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Rodenko more than expected).

Fields of papers citing papers by Boris Rodenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Rodenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Rodenko. The network helps show where Boris Rodenko may publish in the future.

Co-authorship network of co-authors of Boris Rodenko

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Rodenko. A scholar is included among the top collaborators of Boris Rodenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Rodenko. Boris Rodenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Damianou, Andreas, Carolina Moura Costa Catta‐Preta, Vincent Geoghegan, et al.. (2020). Essential roles for deubiquitination in Leishmania life cycle progression. PLoS Pathogens. 16(6). e1008455–e1008455. 33 indexed citations
2.
Damianou, Andreas, et al.. (2020). Leishmania differentiation requires ubiquitin conjugation mediated by a UBC2-UEV1 E2 complex. PLoS Pathogens. 16(10). e1008784–e1008784. 19 indexed citations
3.
Leestemaker, Yves, Annemieke de Jong, Katharina F. Witting, et al.. (2017). Proteasome Activation by Small Molecules. Cell chemical biology. 24(6). 725–736.e7. 117 indexed citations
4.
Berkers, Celia R., Annemieke de Jong, Karianne Schuurman, et al.. (2015). Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules. The Journal of Immunology. 195(9). 4085–4095. 49 indexed citations
5.
Natto, Manal J., et al.. (2012). Validation of novel fluorescence assays for the routine screening of drug susceptibilities of Trichomonas vaginalis. Journal of Antimicrobial Chemotherapy. 67(4). 933–943. 20 indexed citations
6.
Jong, Annemieke de, Remco Merkx, Ilana Berlin, et al.. (2012). Ubiquitin‐Based Probes Prepared by Total Synthesis To Profile the Activity of Deubiquitinating Enzymes. ChemBioChem. 13(15). 2251–2258. 63 indexed citations
8.
Jong, Annemieke de, Karianne Schuurman, Boris Rodenko, Huib Ovaa, & Celia R. Berkers. (2011). Fluorescence-Based Proteasome Activity Profiling. Methods in molecular biology. 803. 183–204. 24 indexed citations
9.
Hadrup, Sine Reker, Mireille Toebes, Boris Rodenko, et al.. (2009). High-Throughput T-Cell Epitope Discovery Through MHC Peptide Exchange. Methods in molecular biology. 524. 383–405. 39 indexed citations
10.
Celie, Patrick H. N., Mireille Toebes, Boris Rodenko, et al.. (2009). UV-Induced Ligand Exchange in MHC Class I Protein Crystals. Journal of the American Chemical Society. 131(34). 12298–12304. 32 indexed citations
11.
Berkers, Celia R., Annemieke de Jong, Huib Ovaa, & Boris Rodenko. (2008). Transpeptidation and reverse proteolysis and their consequences for immunity. The International Journal of Biochemistry & Cell Biology. 41(1). 66–71. 41 indexed citations
12.
Bakker, Arne, Carsten Linnemann, Mireille Toebes, et al.. (2008). Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proceedings of the National Academy of Sciences. 105(10). 3825–3830. 112 indexed citations
13.
Rodenko, Boris, Alida M. van der Burg, Martin J. Wanner, et al.. (2007). 2,N 6 -Disubstituted Adenosine Analogs with Antitrypanosomal and Antimalarial Activities. Antimicrobial Agents and Chemotherapy. 51(11). 3796–3802. 40 indexed citations
14.
Al‐Salabi, Mohammed I., Lynsey J.M. Wallace, Pascal Mäser, et al.. (2006). Molecular Interactions Underlying the Unusually High Adenosine Affinity of a Novel Trypanosoma brucei Nucleoside Transporter. Molecular Pharmacology. 71(3). 921–929. 40 indexed citations
15.
Rodenko, Boris, Mireille Toebes, Sine Reker Hadrup, et al.. (2006). Generation of peptide–MHC class I complexes through UV-mediated ligand exchange. Nature Protocols. 1(3). 1120–1132. 222 indexed citations
16.
Toebes, Mireille, Miriam Coccoris, Adriaan D. Bins, et al.. (2006). Design and use of conditional MHC class I ligands. Nature Medicine. 12(2). 246–251. 248 indexed citations
17.
Rodenko, Boris, et al.. (2005). Biosynthesis and uptake of thiamine (vitamin B1) in bloodstream form Trypanosoma brucei brucei and interference of the vitamin with melarsen oxide activity. International Journal for Parasitology. 36(2). 229–236. 9 indexed citations
18.
Rodenko, Boris, Remko J. Detz, Catia Lambertucci, et al.. (2005). Solid phase synthesis and antiprotozoal evaluation of di- and trisubstituted 5′-carboxamidoadenosine analogues. Bioorganic & Medicinal Chemistry. 14(5). 1618–1629. 18 indexed citations
19.
Wanner, Martin J., et al.. (2004). New (1‐Deaza)Purine Derivatives via Efficient C‐2 Nitration of the (1‐Deaza)Purine Ring. Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1313–1320. 6 indexed citations
20.
Wanner, Martin J., et al.. (2000). New nucleoside analogs, synthesis, and biological properties. Pure and Applied Chemistry. 72(9). 1705–1708. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026